Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.53% is 231% above its 5-year average of 0.16%, near the low end of its 5-year range (0.00%–4.56%).
As of the fiscal period ended Tuesday, June 30, 2026. 72.03% above its 12-month average of 0.31%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.53%.
DEBT TO ASSETS RATIO
0.53%
DEBT TO ASSETS RATIO AVG TTM
0.31%
DEBT TO ASSETS RATIO AVG 3Y
0.18%
DEBT TO ASSETS RATIO AVG 5Y
0.16%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+72.03%
CURRENT VS 3Y AVG
+201.85%
CURRENT VS 5Y AVG
+231.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 589 covered companies
CURRENT VS SECTOR MEDIAN
+431.04%
vs the sector median at left
Context Therapeutics Inc.
Market Cap
$31.91M
Debt to Assets Ratio
0.53%
TTM Avg
0.31%
3Y Avg
0.18%
5Y Avg
0.16%
Market Cap
$31.62M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.23M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.35M
Debt to Assets Ratio
1.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.44M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | $31.91M | 0.53% | 0.31% | 0.18% | 0.16% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.62M | 0.00% | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.23M | 0.19% | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.17M | 0.01% | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.86M | 0.80% | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $33.35M | 1.40% | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.44M | 0.05% | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.46M | 0.00% | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.01M | 0.00% | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $29.61M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.5%
Debt/Equity
0.01
Current Ratio
5.81
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.53% |
| 2026-03-31 | 0.48% |
| 2025-12-31 | 0.16% |
| 2025-09-30 | 0.18% |
| 2025-06-30 | 0.19% |
| 2025-03-31 | 0.21% |
| 2024-12-31 | 0.22% |
| 2024-09-30 | 0.28% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.03% |
| 2023-03-31 | 0.10% |
| 2022-12-31 | 0.15% |
| 2022-09-30 | 0.19% |
| 2022-06-30 | 0.23% |
| 2022-03-31 | 0.26% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 4.56% |
| 2021-03-31 | 5.51% |
| 2020-12-31 | 1273.88% |
